Skip to main content
Clinical Trials/CTRI/2022/07/043879
CTRI/2022/07/043879
Not yet recruiting
未知

Role of Beta-blocker and Norepinephrine in the outcome of stroke

Prinicipal Investigator0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Prinicipal Investigator
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Prinicipal Investigator

Eligibility Criteria

Inclusion Criteria

  • Consecutive patients with CT/MRI proven stroke within 3 days of ictus will be included

Exclusion Criteria

  • Stroke due to arteriovenous malformation, aneurysm, coagulopathy,
  • bleeding disorders, tumor, trauma, patients with hepatic or renal failure, pre\-existing cardiac
  • failure, heart block, renal disease, liver disease, endocrinal disease, HIV, pregnancy,
  • lactation, and those on corticosteroids, norepinephrine, immunosuppressant, chemotherapy
  • and radiotherapy will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials